19 June 2013
Keywords: takeda, alogliptin, submission, european, regulators, delayed, til
Article | 04 June 2009
Japanese drug major Takeda has notified the European Medicines Agency (EMEA) that it will postpone its marketing authorization applications
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 June 2009
18 June 2013
© 2013 thepharmaletter.com